Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
CytoDyn Inc CYDY
(Total Views: 612)
Posted On: 10/28/2020 4:29:29 PM
Post# of 154147
Posted By: Cassandra X
Most people mount a strong antibody response to SARS-CoV-2 that does not decline rapidly: study

https://medicalxpress.com/news/2020-10-people...ponse.html

This study indicates that 90% of mild to moderately ill Covid-19 patients mount an adequate immune response to the virus. No wonder our M/M trial was struggling for statistical significance.

Still, the challenge is to find and prevent the 10% who do not mount an adequate immune response from progressing to something worse.

And who is to say that among the 90% there aren't those who suffer organ and health compromise? Are the recovered really recovered in this group?

This pandemic has certainly created a rich field for medical investigation that will, hopefully, bear much fruit for future health knowledge.













(1)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site